186 related articles for article (PubMed ID: 25645303)
1. pH-Responsive Reversible PEGylation Improves Performance of Antineoplastic Agent.
Sun D; Ding J; Xiao C; Chen J; Zhuang X; Chen X
Adv Healthc Mater; 2015 Apr; 4(6):844-55. PubMed ID: 25645303
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of antitumor activity of acid-sensitive PEGylated doxorubicin.
Sun D; Ding J; Xiao C; Chen J; Zhuang X; Chen X
ACS Appl Mater Interfaces; 2014 Dec; 6(23):21202-14. PubMed ID: 25415351
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment-labile polymer-doxorubicin conjugate thermogel combined with docetaxel for in situ synergistic chemotherapy of hepatoma.
Zhang Y; Zhang J; Xu W; Xiao G; Ding J; Chen X
Acta Biomater; 2018 Sep; 77():63-73. PubMed ID: 30006312
[TBL] [Abstract][Full Text] [Related]
4. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
5. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
Xu M; Qian J; Liu X; Liu T; Wang H
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
[TBL] [Abstract][Full Text] [Related]
6. Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditions.
Wu L; Zou Y; Deng C; Cheng R; Meng F; Zhong Z
Biomaterials; 2013 Jul; 34(21):5262-72. PubMed ID: 23570719
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
[TBL] [Abstract][Full Text] [Related]
8. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534
[TBL] [Abstract][Full Text] [Related]
9. Oxime linkage: a robust tool for the design of pH-sensitive polymeric drug carriers.
Jin Y; Song L; Su Y; Zhu L; Pang Y; Qiu F; Tong G; Yan D; Zhu B; Zhu X
Biomacromolecules; 2011 Oct; 12(10):3460-8. PubMed ID: 21863891
[TBL] [Abstract][Full Text] [Related]
10. pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy.
Hu FQ; Zhang YY; You J; Yuan H; Du YZ
Mol Pharm; 2012 Sep; 9(9):2469-78. PubMed ID: 22827551
[TBL] [Abstract][Full Text] [Related]
11. pH-Responsive Poly(ethylene glycol)/Poly(L-lactide) Supramolecular Micelles Based on Host-Guest Interaction.
Zhang Z; Lv Q; Gao X; Chen L; Cao Y; Yu S; He C; Chen X
ACS Appl Mater Interfaces; 2015 Apr; 7(16):8404-11. PubMed ID: 25856564
[TBL] [Abstract][Full Text] [Related]
12. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
[TBL] [Abstract][Full Text] [Related]
13. Smart pH-responsive nanocarriers based on nano-graphene oxide for combined chemo- and photothermal therapy overcoming drug resistance.
Feng L; Li K; Shi X; Gao M; Liu J; Liu Z
Adv Healthc Mater; 2014 Aug; 3(8):1261-71. PubMed ID: 24652715
[TBL] [Abstract][Full Text] [Related]
14. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release.
Chen W; Zhong P; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
J Control Release; 2013 Aug; 169(3):171-9. PubMed ID: 23306022
[TBL] [Abstract][Full Text] [Related]
15. Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release.
Zhou H; Sun H; Lv S; Zhang D; Zhang X; Tang Z; Chen X
Acta Biomater; 2017 May; 54():227-238. PubMed ID: 28315495
[TBL] [Abstract][Full Text] [Related]
16. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472
[TBL] [Abstract][Full Text] [Related]
17. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z
Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663
[TBL] [Abstract][Full Text] [Related]
18. pH-sensitive degradable chimaeric polymersomes for the intracellular release of doxorubicin hydrochloride.
Du Y; Chen W; Zheng M; Meng F; Zhong Z
Biomaterials; 2012 Oct; 33(29):7291-9. PubMed ID: 22795540
[TBL] [Abstract][Full Text] [Related]
19. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]